{"url":"https://lda.senate.gov/api/v1/filings/0f5cdbfe-d19d-4247-83f2-f2e5572edc15/?format=json","filing_uuid":"0f5cdbfe-d19d-4247-83f2-f2e5572edc15","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/0f5cdbfe-d19d-4247-83f2-f2e5572edc15/print/","filing_document_content_type":"text/html","income":"45000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Joseph R Murray","dt_posted":"2026-06-11T09:53:52-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Pennsylvania Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401104348,"url":"https://lda.senate.gov/api/v1/registrants/401104348/?format=json","house_registrant_id":null,"name":"FIRST PRINCIPLES STRATEGIES, LLC","description":"Federal government affairs & strategic communications","address_1":"601 Pennsylvania Avenue, NW","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOSEPH MURRAY","contact_telephone":"+1 703-307-1274","dt_updated":"2026-01-31T12:30:18.406819-05:00"},"client":{"id":68482,"url":"https://lda.senate.gov/api/v1/clients/68482/?format=json","client_id":68482,"name":"AMERICAN LABORATORIES PHARMA, LLC","general_description":"Health & Wellness Manufacturer","client_government_entity":null,"client_self_select":false,"state":"NE","state_display":"Nebraska","country":"US","country_display":"United States of America","ppb_state":"NE","ppb_state_display":"Nebraska","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-07-11"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Importation policies of active pharmaceutical ingredients","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":69055,"prefix":null,"prefix_display":null,"first_name":"JOSEPH","nickname":null,"middle_name":"ROBERT","last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":"Republican Study Committee; Rep. Mark Meadows; Senator Ron Johnson","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}